Streetbeat News

PBLA

Panbela Therapeutics Inc.

http://www.sunbiopharma.com/

CEO

Michael Cullen

Open

0.37

Mkt cap

1.8M

Volume

605

High

0.37

P/E Ratio

-0.01

52-wk high

1.11

Low

0.37

Div yield

N/A

52-wk low

0.30

The article provides an overview of value stocks in the healthcare sector, focusing on companies with low price-to-earnings (P/E) multiples, suggesting potential undervaluation. Notable stocks mentioned include Agile Therapeutics (AGRX), Panbela Therapeutics (PBLA), Procaps Gr (PROC), Exicure (XCUR), and Zymeworks (ZYME), with their respective P/E ratios and recent earnings per share (EPS) data. The article highlights the inherent risk in value stocks, as their undervalued position may not always lead to a rebound.

Portfolio Pulse from Benzinga Insights

January 15, 2024 | 2:42 pm

The article lists 5 value stocks in the healthcare sector, selected by Benzinga Insights based on their low price-to-earnings (P/E) multiples, suggesting potential undervaluation. The stocks include Syros Pharmaceuticals (SYRS), BioNTech (BNTX), Cross Country Healthcare (CCRN), Solid Biosciences (SLDB), and Panbela Therapeutics (PBLA). The article provides recent earnings per share (EPS) data for these companies, indicating their financial performance in the most recent quarter compared to the previous one.

Portfolio Pulse from Benzinga Insights

January 01, 2024 | 2:43 pm

In Wednesday's after-market session, several healthcare stocks experienced significant movements. Cyclo Therapeutics (CYTH) saw a 34.1% increase, while Cingulate (CING) rose by 22.05%. Virax Biolabs Group (VRAX) and Inspire Veterinary (IVP) also saw gains of 10.69% and 8.64%, respectively. On the downside, Edgewise Therapeutics (EWTX) dropped by 14.5%, NKGen Biotech (NKGN) by 9.64%, and Panbela Therapeutics (PBLA) by 6.13%. Other losers included Ampio Pharmaceuticals (AMPE), Autolus Therapeutics (AUTL), and Nuwellis (NUWE) with declines of 5.91%, 5.9%, and 5.77%, respectively.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 9:31 pm

In Tuesday's pre-market session, several healthcare stocks experienced significant movements. RayzeBio (RYZB) saw a dramatic increase of 98.2%, while Gracell Biotechnologies (GRCL) and 60 Degrees (SXTP) also posted substantial gains. Conversely, Milestone Pharmaceuticals (MIST) and other stocks such as SINTX Techs (SINT) and Panbela Therapeutics (PBLA) faced notable declines. These movements reflect changes in investor sentiment and market dynamics affecting these companies' valuations.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 1:07 pm

Sentage Holdings Inc. (SNTG) shares dropped by 5.1% in pre-market trading after reporting a loss of 46 cents per share for the six months ended June 30, 2023, compared to a loss of 41 cents per share in the previous year. The company's total operating revenue was $82, down from $0.18 million year-over-year. Other stocks experienced pre-market movements, with notable gainers including Volcon, Inc. (VLCN), Gracell Biotechnologies Inc. (GRCL), and AERWINS Technologies Inc. (AWIN), and significant losers such as NextPlay Technologies, Inc. (NXTP), Prospector Capital Corp. (LDTC), and Vroom, Inc. (VRM).

Portfolio Pulse from Avi Kapoor

December 26, 2023 | 1:01 pm

Panbela Therapeutics' stock is trading lower following the announcement of a $2 million private placement deal involving existing warrants for 2,556,000 shares at $0.78 each.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 8:30 pm

U.S. stocks closed higher with the Dow Jones gaining over 100 points. CarMax, Inc. (KMX) shares rose after reporting Q3 earnings that beat estimates with EPS of $0.52, despite a sales decline of 5.5%. Triumph Group (TGI) surged 32% after announcing the sale of its Product Support business to AAR. HOOKIPA Pharma (HOOK) jumped 76% following a $21.25 million equity investment from Gilead Sciences. Annexon (ANNX) gained 21% after reporting positive study results. Conversely, Panbela Therapeutics (PBLA), Clene Inc. (CLNN), and Longeveron (LGVN) saw significant declines in their share prices.

Portfolio Pulse from Avi Kapoor

December 21, 2023 | 7:23 pm

CarMax, Inc. (NYSE:KMX) shares rose by approximately 8% following its quarterly earnings report, which showed an EPS of $0.52, surpassing the consensus estimate of $0.44, despite a 5.5% year-on-year sales decline. Other stocks experienced significant movements in Thursday's mid-day session, with various companies reporting investments, acquisitions, and regulatory updates that influenced their stock prices.

Portfolio Pulse from Avi Kapoor

December 21, 2023 | 6:01 pm

In Thursday's intraday session, several healthcare stocks experienced significant movements. HOOKIPA Pharma (HOOK) saw a 73.2% increase, while HeartBeam (BEAT) rose by 54.23%. PetVivo Holdings (PETV), OneMedNet (ONMD), Anebulo Pharmaceuticals (ANEB), and MeiraGTx Holdings (MGTX) also saw upward movements ranging from 27.89% to 39.02%. On the downside, Clene (CLNN) dropped by 41.5%, Aclarion (ACON) by 28.06%, Panbela Therapeutics (PBLA) by 24.47%, Longeveron (LGVN) by 22.05%, Genetic Technologies (GENE) by 15.37%, and Know Labs (KNW) by 13.51% after their Q4 earnings report was released two days ago.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 5:32 pm

U.S. stocks traded higher with the Nasdaq Composite gaining over 100 points. Health care shares led gains, while energy shares dipped slightly. Micron Technology (NASDAQ:MU) reported Q1 revenue above estimates but a larger loss per share than expected, and issued strong guidance. ParaZero Technologies (NASDAQ:PRZO), HOOKIPA Pharma (NASDAQ:HOOK), and DMK Pharmaceuticals (NASDAQ:DMK) saw significant stock increases. Panbela Therapeutics (NASDAQ:PBLA), Clene Inc. (NASDAQ:CLNN), and Longeveron Inc. (NASDAQ:LGVN) experienced notable declines. Crude oil prices fell, while gold saw a slight increase.

Portfolio Pulse from Avi Kapoor

December 21, 2023 | 4:59 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.